DORVAL ALLISON sold 13.3% of their position (11.61K shares) of PUMA BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $39.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/17/2025ACC: 0001437749-25-020713
-11.61K
Net shares
Net seller
$39.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
11.61K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.61K
Price / share
$3.40
Trade value
$39.47K
% of position
13.3%
6/13/2025
87K→75.39K
Total
Net shares
−11.61K
Net value
-$39.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2025 | S · Sale | −11.61K | $3.40 | $39.47K | 13.3% | 87K | 75.39K |
| Total | −11.61K | -$39.47K | ||||||
Derivative Transactions0
No derivative transactions reported